Identification of unique sensitizing targets for anti‐inflammatory CDDO‐Me in metastatic melanoma by a large‐scale synthetic lethal RNAi screening
- 1 October 2012
- journal article
- research article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 26 (1), 97-112
- https://doi.org/10.1111/pcmr.12031
Abstract
CDDO‐Me has been shown to exert potent anti‐inflammatory activity for chronic kidney disease and antitumor activity for several tumors, including melanoma, in early clinical trials. To improve CDDO‐Me response in melanoma, we utilized a large‐scale synthetic lethal RNAi screen targeting 6000 human druggable genes to identify targets that would sensitize melanoma cells to CDDO‐Me. Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO‐Me and induced apoptosis in A375, a BRAF mutated melanoma line (P < 0.001). These five genes were then individually validated as targets to potentiate CDDO‐Me activity, and related downstream signaling pathways of these genes were analyzed. In addition, the levels of phosphorylated Erk1/2, Akt, GSK‐2, and PRAS40 were dramatically decreased by downregulating each of these five genes separately, suggesting a set of common mediators. Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO‐Me efficacy in melanoma growth control.Keywords
This publication has 43 references indexed in Scilit:
- Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human MelanomaMolecular Cancer Research, 2011
- Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in CancerClinical Cancer Research, 2010
- Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with ChemotherapyClinical Cancer Research, 2010
- NF-κB Mediates Mitogen-Activated Protein Kinase Pathway-Dependent iNOS Expression in Human MelanomaJournal of Investigative Dermatology, 2009
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cellsCancer Chemotherapy and Pharmacology, 2008
- Triterpenoid CDDO-Methyl Ester Inhibits the Janus-Activated Kinase-1 (JAK1)→Signal Transducer and Activator of Transcription-3 (STAT3) Pathway by Direct Inhibition of JAK1 and STAT3Cancer Research, 2008
- Preclinical Evaluation of Targeting the Nrf2 Pathway by Triterpenoids (CDDO-Im and CDDO-Me) for Protection from LPS-Induced Inflammatory Response and Reactive Oxygen Species in Human Peripheral Blood Mononuclear Cells and NeutrophilsAntioxidants and Redox Signaling, 2007
- Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian womenJournal of Carcinogenesis, 2007
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- A Genetic Screen for Candidate Tumor Suppressors Identifies RESTCell, 2005